PubRank

Long-Cheng Li

Author PubWeight™ 56.80‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 MicroRNA-373 induces expression of genes with complementary promoter sequences. Proc Natl Acad Sci U S A 2008 6.38
2 Transient focal ischemia induces extensive temporal changes in rat cerebral microRNAome. J Cereb Blood Flow Metab 2009 2.87
3 Upregulation of Cyclin B1 by miRNA and its implications in cancer. Nucleic Acids Res 2011 1.84
4 RNAa is conserved in mammalian cells. PLoS One 2010 1.81
5 Epigenetic inactivation of Wnt inhibitory factor-1 plays an important role in bladder cancer through aberrant canonical Wnt/beta-catenin signaling pathway. Clin Cancer Res 2006 1.73
6 Intravesical delivery of small activating RNA formulated into lipid nanoparticles inhibits orthotopic bladder tumor growth. Cancer Res 2012 1.65
7 Prognostic value and function of KLF4 in prostate cancer: RNAa and vector-mediated overexpression identify KLF4 as an inhibitor of tumor cell growth and migration. Cancer Res 2010 1.54
8 miR-449a causes Rb-dependent cell cycle arrest and senescence in prostate cancer cells. Oncotarget 2010 1.53
9 The E-cadherin -160 C/A polymorphism and prostate cancer risk in white and black American men. J Urol 2006 1.43
10 Antitumor effect of dsRNA-induced p21(WAF1/CIP1) gene activation in human bladder cancer cells. Mol Cancer Ther 2008 1.39
11 Small RNA and transcriptional upregulation. Wiley Interdiscip Rev RNA 2011 1.36
12 Increased heparanase expression is caused by promoter hypomethylation and up-regulation of transcriptional factor early growth response-1 in human prostate cancer. Clin Cancer Res 2005 1.25
13 Multigene methylation analysis for detection and staging of prostate cancer. Clin Cancer Res 2005 1.18
14 Ago1 Interacts with RNA polymerase II and binds to the promoters of actively transcribed genes in human cancer cells. PLoS Genet 2013 1.18
15 Smoking influences aberrant CpG hypermethylation of multiple genes in human prostate carcinoma. Cancer 2006 1.17
16 Effects of transplantation of adipose tissue-derived stem cells on prostate tumor. Prostate 2010 1.15
17 Cytochrome P450 1B1 is overexpressed and regulated by hypomethylation in prostate cancer. Clin Cancer Res 2005 1.14
18 A component of green tea, (-)-epigallocatechin-3-gallate, promotes apoptosis in T24 human bladder cancer cells via modulation of the PI3K/Akt pathway and Bcl-2 family proteins. Biochem Biophys Res Commun 2007 1.09
19 Functional Loss of the gamma-catenin gene through epigenetic and genetic pathways in human prostate cancer. Cancer Res 2005 1.09
20 Defining features and exploring chemical modifications to manipulate RNAa activity. Curr Pharm Biotechnol 2010 1.09
21 Ethnic group-related differences in CpG hypermethylation of the GSTP1 gene promoter among African-American, Caucasian and Asian patients with prostate cancer. Int J Cancer 2005 1.06
22 CpG hypermethylation of MDR1 gene contributes to the pathogenesis and progression of human prostate cancer. Cancer Res 2004 1.05
23 CpG methylation at promoter site -140 inactivates TGFbeta2 receptor gene in prostate cancer. Cancer 2005 1.00
24 Epigenetic inactivation of the dioxin-responsive cytochrome P4501A1 gene in human prostate cancer. Cancer Res 2006 0.96
25 Targeted induction of endogenous NKX3-1 by small activating RNA inhibits prostate tumor growth. Prostate 2013 0.95
26 Targeted p21WAF1/CIP1 activation by RNAa inhibits hepatocellular carcinoma cells. Nucleic Acid Ther 2012 0.94
27 Chromatin changes on the GSTP1 promoter associated with its inactivation in prostate cancer. Mol Carcinog 2007 0.94
28 miR-663 induces castration-resistant prostate cancer transformation and predicts clinical recurrence. J Cell Physiol 2014 0.93
29 Induction of NANOG expression by targeting promoter sequence with small activating RNA antagonizes retinoic acid-induced differentiation. Biochem J 2012 0.93
30 Comparison of open surgery versus retroperitoneoscopic approach to chyluria. J Urol 2003 0.92
31 Formulation of Small Activating RNA Into Lipidoid Nanoparticles Inhibits Xenograft Prostate Tumor Growth by Inducing p21 Expression. Mol Ther Nucleic Acids 2012 0.91
32 Identification of an aberrant cell line among human adipose tissue-derived stem cell isolates. Differentiation 2008 0.91
33 Retroperitoneal laparoscopic nephron-sparing surgery for renal tumors: report of 32 cases. Urology 2005 0.89
34 An orthotopic bladder tumor model and the evaluation of intravesical saRNA treatment. J Vis Exp 2012 0.87
35 miRNA goes nuclear. RNA Biol 2012 0.87
36 Relationship between glucocorticoid receptor signal pathway and androgen-independent prostate cancer. Urol Int 2008 0.86
37 Retroperitoneoscopic subcapsular nephrectomy for infective nonfunctioning kidney with dense perinephric adhesions. BJU Int 2004 0.84
38 CpG hypermethylation of promoter region and inactivation of E-cadherin gene in human bladder cancer. Mol Carcinog 2002 0.84
39 Comparison of retroperitoneoscopic nephrectomy versus open approaches to nonfunctioning tuberculous kidneys: a report of 44 cases. J Urol 2005 0.84
40 Small RNA and its application in andrology and urology. Transl Androl Urol 2012 0.84
41 MicroRNA regulation of neuron-like differentiation of adipose tissue-derived stem cells. Differentiation 2009 0.82
42 Association between a C/A single nucleotide polymorphism of the E-cadherin gene promoter and transitional cell carcinoma of the bladder. J Urol 2003 0.81
43 Adaptation and clonal selection models of castration-resistant prostate cancer: current perspective. Int J Urol 2012 0.80
44 Identification of small activating RNAs that enhance endogenous OCT4 expression in human mesenchymal stem cells. Stem Cells Dev 2014 0.80
45 saRNA guided iNOS up-regulation improves erectile function of diabetic rats. J Urol 2013 0.79
46 Kidney gene database: a curated and integrated database of genes involved in kidney disease. J Urol 2004 0.78
47 RNAa in action: from the exception to the norm. RNA Biol 2014 0.78
48 Transforming growth factor-beta(s) and their receptors in aging rat prostate. Biochem Biophys Res Commun 2002 0.75